Castle Biosciences Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 201
Employees
  • Stock Symbol
  • CSTL
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $71.89
  • (As of Friday Closing)

Castle Biosciences General Information

Description

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 505 South Friendswood Drive
  • Suite 401
  • Friendswood, TX 77546
  • United States
+1 (866) 000-0000

Castle Biosciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Castle Biosciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$71.89 $71.22 $34.72 - $107.69 $1.8B 25.1M 278K -$0.71

Castle Biosciences Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,300,171 1,501,755 517,264
Revenue 68,044 62,649 51,865 22,786
EBITDA (13,140) (7,467) 9,966 (3,785)
Net Income (15,134) (10,284) 5,277 (6,367)
Total Assets 437,332 439,328 119,746 22,405
Total Debt 0 0 25,122 24,500
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Castle Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Castle Biosciences‘s full profile, request access.

Request a free trial

Castle Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Castle Biosciences‘s full profile, request access.

Request a free trial

Castle Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and th
Laboratory Services (Healthcare)
Friendswood, TX
201 As of 2020
00000
00000000 00000

00000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
0000000000 000000000
Redwood City, CA
000 As of 0000
00000
000000 - 000 00000

000000 0

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000000000000
Salt Lake City, UT
0000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Castle Biosciences Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Guardant Health Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
00000000 Corporation Boston, MA 0 000.00 000000000 000.00
00000000 Private Equity-Backed Holliston, MA 00 000.00 000000000 - 000.00
0000000000 0000000 Venture Capital-Backed San Diego, CA 00 000.00 000000000 - 000.00
You’re viewing 5 of 24 competitors. Get the full list »

Castle Biosciences Executive Team (15)

Name Title Board Seat Contact Info
Derek Maetzold Chief Executive Officer & Board Member
Franklin Stokes JD Chief Financial Officer
Kristen Oelschlager Chief Operating Officer, Operations
Noreen Manning Executive Director of Reimbursement
Bernhard Spiess Executive
You’re viewing 5 of 15 executive team members. Get the full list »

Castle Biosciences Board Members (13)

Name Representing Role Since
Bonnie Anderson Self Board Member 000 0000
Daniel Bradbury Biobrit Chairman & Board Member 000 0000
David Kabakoff Ph.D Self Board Member 000 0000
Derek Maetzold Castle Biosciences Chief Executive Officer & Board Member 000 0000
G. Cole Castle Biosciences Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Castle Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Castle Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Castle Biosciences‘s full profile, request access.

Request a free trial

Castle Biosciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 28-May-2021 000000000000000000 000.00 Diagnostic Equipment 00000 00000000
To view Castle Biosciences’s complete acquisitions history, request access »